Peer Review History
| Original SubmissionFebruary 1, 2024 |
|---|
|
PONE-D-24-01790Widespread use of ChatGPT and other Artificial Intelligence tools among medical students in Uganda: a cross-sectional studyPLOS ONE Dear Dr. Nantale, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ACADEMIC EDITOR:In addition to the reviewers' comments,1. Data visualization could be improved. Could we present some of the figures using charts other than bar graphs?. For bar charts, please indicate the axis titles.2. Please expand the DISCUSSION. There are new reports on this aspect in other countries, which may make your discussion robust, and probably lead to more meaningful conclusions. Weidener L, Fischer M. Artificial Intelligence in Medicine: Cross-Sectional Study Among Medical Students on Application, Education, and Ethical Aspects. JMIR Med Educ 2024;10:e51247https://mededu.jmir.org/2024/1/e51247Kapsali M, Livanis E, Tsalikidis C, Oikonomou P, Voultsos P, Tsaroucha A. Ethical Concerns About ChatGPT in Healthcare: A Useful Tool or the Tombstone of Original and Reflective Thinking?. Cureus 2024, 16(2): e54759. doi:10.7759/cureus.54759Heredia-Negrón, F.; Tosado-Rodríguez, E.L.; Meléndez-Berrios, J.; Nieves, B.; Amaya-Ardila, C.P.; Roche-Lima, A. Assessing the Impact of AI Education on Hispanic Healthcare Professionals’ Perceptions and Knowledge. Educ. Sci. 2024, 14, 339. https://doi.org/10.3390/educsci14040339McLennan S, Meyer A, Schreyer K, Buyx A (2022) German medical students´ views regarding artificial intelligence in medicine: A cross-sectional survey. PLOS Digit Health 1(10): e0000114. https://doi.org/10.1371/journal.pdig.00001143. It is necessary to indicate the potential limitations of the study, just as you indicated the strengths. 4. Your conclusions should be expanded in the broader context, and should preferably give some directions for future reseach. Please submit your revised manuscript by May 08 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Timothy Omara Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Your ethics statement should only appear in the Methods section of your manuscript. If your ethics statement is written in any section besides the Methods, please move it to the Methods section and delete it from any other section. Please ensure that your ethics statement is included in your manuscript, as the ethics statement entered into the online submission form will not be published alongside your manuscript. 3. We note you have included a table to which you do not refer in the text of your manuscript. Please ensure that you refer to Table 1 and 2 in your text; if accepted, production will need this reference to link the reader to the Table. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: No ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: I am pleased to give my thoughts on the article titled 'Widespread Use of ChatGPT and Other Artificial Intelligence Tools Among Medical Students in Uganda: A Cross-Sectional Study.' Overall, it appears to be a promising article of good quality. However, it can be improved. Title: The title could be improved removing redundant words by specifying the type of AI tools examined in the study. For example, "Widespread use of ChatGPT and Other Artificial Intelligence Tools among Medical Students in Uganda: A Cross-Sectional Study." Abstract: Consider including specific findings or percentages in the abstract to give readers a clearer understanding of the key results. Also, mentioning the implications of the findings in the abstract would enhance its significance. Introduction: The introduction effectively sets the context by explaining the significance of AI tools like ChatGPT in medical education. However, it could be strengthened by providing more context on the challenges faced by medical education due to the widespread adoption of AI tools. Consider integrating more recent literature or studies to emphasize the relevance and timeliness of the research. Materials and Methods: Provide more details on the semi-structured questionnaire used, including the specific questions related to AI tool usage. Describe the process of questionnaire adaptation and validation, if applicable, to ensure the reliability of data collection instruments. Mention the steps taken to ensure the confidentiality and anonymity of participants' responses. Results: The results section presents the key findings of the study in a structured manner. Discussion: The discussion effectively contextualizes the findings within existing literature and highlights their implications. However, the authors should provide a more detailed comparison of the study findings with similar research conducted in other settings or populations. While the authors discuss the strength of the, they should consider discussing potential limitations of the study and their impact on the interpretation of results. Also, propose recommendations for future research or practical interventions based on the study findings. Conclusion: Consider reiterating the implications of the study findings for medical education policy and practice. Provide clear recommendations for addressing the challenges and opportunities associated with the widespread use of AI tools among medical students. Avoid introducing new information or findings in the conclusion section. Ethical Approval and Consent to Participate: Consider including information on how participants were informed about the study objectives, risks, and benefits before obtaining their consent. Specify whether any incentives or compensation were provided to participants for their involvement in the study. General Comments: The article would benefit from thorough proofreading to correct grammatical errors, typos, and formatting inconsistencies. Reviewer #2: 1. “In order to exploit the use of ChatGPT and other related AI software, there is an urgent need to develop guidelines.” – do the authors mean to say, in order to prevent exploitation? 2. What were the measures taken to reduce social desirability bias in the study? Will students actually acknowledge its use for plagiarism? 3. Are there any guidelines in developed countries / HMICs on how to use AI tools? 4. How can guidelines be formed to limit its misuse? – Will universities / journals check for AI written content? 5. “Almost all 93% (522/564) had ever had about AI tools 155 such as ChatGPT.” – Needs to be rephrased 6. “Most 71%” – most and percentage should be avoided together 7. Results need to be rewritten in a better language 8. “Medical students aged 35 to 46 years were 31% less likely to use AI tools as compared to those aged less than 35 years” – Are undergraduate medical students aged above 35, this is highly unusual across the world? Also can 13 really be compared against 47 and 77 to draw such a definite conclusion? 9. While the study provides insights on the patterns on Generative AI use, and the need for regulatory guidelines – Can the authors discuss steps taken in other countries to reduce its misuse. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Dr. Amir Kabunga Reviewer #2: Yes: Rajmohan Seetharaman ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-24-01790R1Widespread use of ChatGPT and other Artificial Intelligence tools among medical students in Uganda: a cross-sectional studyPLOS ONE Dear Dr. Nantale, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 10 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Timothy Omara, PhD Academic Editor PLOS ONE Additional Editor Comments: Dear authors, The reviewers have re-assessed your resubmission. However, there are still suggestions that need to be incorporated. In addition to reviewer comments, I suggest taking a closer look at the following aspects of the draft. 1. Table 1 seems not to be properly reported. I would expect that it gives a general overview of the overall sociodemographic characteristics of the respondents (irrespective of whether or not they have ever used ChatGPT or any other such LLM). Please refer to my suggestions in the manuscript file attached. 2. It is also evident that percentage calculations in Figures 1, 2 and 3 are erroneous. For example, the total percentage in Figure 1 is 118% instead of 100%. Figure 3 has total percentage less than 100%. It would be expected to group academic and non-academic uses of these LLM together, because this is the collective sum of what students attested to using them for. 3. After these revisions, you may have to redo statistical analysis and change some parts of the abstract, results, discussion and conclusions. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: No ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Thank you for the opportunity to re-review this article. Unfortunately, many of the comments previously provided to the authors have not been adequately addressed. The authors should carefully reconsider each of my comments and provide more thorough responses, as the current revisions appear to be only superficial attempts to resolve the issues with the manuscript. 1. “In order to exploit the use of ChatGPT and other related AI software, there is an urgent need to develop guidelines.” – do the authors mean to say, in order to prevent exploitation?Thank you for your comment. With exploiting, we refer to making use of. We have rephrased it to “AI tools can address faculty shortages, support research, and innovation, and advance critical thinking skills. In order to fully exploit these benefits, there is an urgent need to develop institutional AI policies and guidelines, thereby harnessing the advantages while mitigating associated risks in medical education” Reviewers comment on the response: Please replace “exploit” word with a synonym. 2. What were the measures taken to reduce social desirability bias in the study? Will students actually acknowledge its use for plagiarism?To reduce social desirability bias, we used a self-administered questionnaire.136 Reviewers comment on the response: Please explain how can self-administered questionnaire reduce social desirability bias? E.g. “Anonymity, reduced social pressure, privacy, lack of non-verbal cues, and standardized responses in self-administered questionnaires help minimize social desirability bias, leading to more accurate and reliable data collection.” 3. Are there any guidelines in developed countries / HMICs on how to use AI tools? Yes, there are guidelines in some high-income countries on AI use in educationN/A Reviewers comment on the response: If yes then this should be mentioned and cited in the manuscript including name of the guidelines. 4. How can guidelines be formed to limit its misuse? – Will universities / journals check for AI written content?There are attempts to check for AI written content. However, most of these tools are not yet validated. Reviewers comment on the response: Give examples and cite in the manuscript. 5. “Almost all 93% (522/564) had ever had about AI tools 155 such as ChatGPT.” – Needs to be rephrasedThank you, this has been rephrased.162 Reviewers comment on the response: Rephrasing language not up to the mark. 6. “Most 71%” – most and percentage should be avoided togetherThank you, this has been rephrased.163 Reviewers comment on the response: This is still there in the abstract “most (72.2%) had ever used ChatGPT” 7. Results need to be rewritten in a better languageThank you, this has been done.158-204 Reviewers comment on the response: This has been adequately addressed 8. “Medical students aged 35 to 46 years were 31% less likely to use AI tools as compared to those aged less than 35 years” – Are undergraduate medical students aged above 35, this is highly unusual across the world? Also can 13 really be compared against 47 and 77 to draw such a definite conclusion?We understand your concern. However, in Uganda, there are undergraduate medical students who are aged more than 35 years. These majorly include those who study medical course at diploma level and later join medical school for a medical undergraduate bachelor degree.N/A Reviewers comment on the response: This needs to be explained in the discussion, to avoid conflicting remarks by readers. 9. While the study provides insights on the patterns on Generative AI use, and the need for regulatory guidelines – Can the authors discuss steps taken in other countries to reduce its misuse.Thank you, we have discussed these as indicated. Other countries have developed AI policies and guidelines to prevent AI misuse.274-280 Reviewers comment on the response: This discussion is very superficial. It needs a very indepth discussion – examples of universities / guideline names also need to be cited. The authors need to mention about the indepth policies. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Rajmohan Seetharaman ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Widespread use of ChatGPT and other Artificial Intelligence tools among medical students in Uganda: a cross-sectional study PONE-D-24-01790R2 Dear Dr. Nantale, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Timothy Omara Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: Thank you for addressing all requested revisions. The manuscript now includes a suitable synonym for "exploit," clarifies measures taken to reduce social desirability bias, cites specific AI guidelines from high-income countries, and provides examples of tools to detect AI content. Language improvements enhance clarity, and the discussion now explains age-related AI tool usage and international regulatory policies. These updates meet the review requirements, and I recommend the manuscript for acceptance. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: Yes: Rajmohan Seetharaman ********** |
| Formally Accepted |
|
PONE-D-24-01790R2 PLOS ONE Dear Dr. Nantale, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Timothy Omara Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .